Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
This duration of this trial is 11 weeks.
Age
18–64
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a diagnosis of major depressive disorder, as defined by the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR) criteria (296.3) and confirmed by the semi-structured Mini International Neuropsychiatric Interview (MINI).
You may not be if
Inpatient hospitalization at screening
Symptoms of depression present for \<30 days or \>2 years
Significant suicide risk
Mild depression as measured by standard clinical research scales
History of failure to respond to antidepressant treatment
Other psychiatric conditions that could obscure the results of the study
For women of child-bearing potential, the unwillingness to use highly effective means of birth control
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Clareo Health | A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder
